Bing Quan

机构：Fudan University, Ministry of Education · ORCID：0000-0003-1821-2274

发表论文 48 篇 · 总被引 493 次 · h-index 11

代表论文

• Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment (2022 · Cellular and Molecular Gastroenterology and Hepatology · 被引 33)
• First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials (2021 · Frontiers in Oncology · 被引 30)
• LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. (2023 · PubMed · 被引 28)
• DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC (2024 · Cellular and Molecular Gastroenterology and Hepatology · 被引 16)
• NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma (2023 · MedComm · 被引 12)
• PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma (2022 · Diagnostics · 被引 12)